Business Segments

6 Months Ended

Jul. 02, 2022

Segment Reporting [Abstract]

Business Segments

11. Business Segments

The Company operates in one segment, ophthalmology. The Company develops, manufactures and markets medical devices. Our revenues arise from the sale of consoles, delivery devices, consumables, service, and support activities.

Revenue information shown by product group is as follows:

	Three Months Ended				Six Months Ended
(in thousands)	July 2, 2022		July 3, 2021		July 2, 2022		July 3, 2021
Cyclo G6	$	3,477	$	3,599	$	7,017	$	6,948
Retina		7,529		7,575		14,830		14,235
Other(1)		2,749		2,252		5,295		4,202
Total revenues	$	13,755	$	13,426	$	27,142	$	25,385

(1) Includes service contract revenues of $402 and $375 and $764 and $674 recognized during the three and six months ended July 2, 2022 and July 3, 2021, respectively. Includes $357 and $634 and $0 and $111 recognized revenue related to the exclusive distribution rights during the three and six months ended July 2, 2022 and July 3, 2021, respectively. Other also includes revenues from paid service, royalty, freight and legacy G probes.

Revenue information shown by geographic region, based on the sales destination, is as follows:

	Three Months Ended				Six Months Ended
(in thousands)	July 2, 2022		July 3, 2021		July 2, 2022		July 3, 2021
United States	$	6,849	$	6,396	$	13,391	$	11,960
Europe		2,821		3,293		6,252		5,710
Asia/Pacific Rim		3,185		3,342		6,039		6,516
Rest of Americas		900		395		1,460		1,199
Total revenues	$	13,755	$	13,426	$	27,142	$	25,385

Revenues are attributed to countries based on the location of end customers.

Other than the United States, no individual country accounted for at least 10% of the Company’s revenues during the three and six months ended July 2, 2022. Other than the United States, Japan accounted for more than 10% of the Company’s revenues during the three and six months ended July 3, 2021, representing 12% and 14%, respectively. The United States accounted for 49.8% and 47.6% of revenues for the three months ended July 2, 2022 and July 3, 2021, respectively, and for 49.3% and 47.1% of revenues for the six months ended July 2, 2022 and July 3, 2021, respectively.